Bariatric Surgery for the Reduction of cArdioVascular Events Feasibility Trial

NCT04226664 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-03-15

No results posted yet for this study

Summary

Pilot multicentre, open-label, parallel-arm randomized controlled trial (RCT) of 60 patients to demonstrate the feasibility of enrolling patients with high-risk cardiovascular disease (CVD) into an RCT of bariatric surgery versus medical weight management (MWM).

Conditions

Interventions

PROCEDURE

Bariatric surgery

Although there may be slight variation by centre, Gastric Bypass generally involves creation of a 30-50 cc stomach pouch, which is anastamosed with a Roux limb of jejunum 75-100 cm in length and a biliary limb of 20-30 cm in length. The operation creates a small gastric pouch, with nutrients bypassing the duodenum and proximal jejunum. Sleeve Gastrectomy involves decreasing the size of the stomach to approximately 15% of its original size by resecting a large portion of the stomach along the greater curvature.

Sponsors & Collaborators

  • Population Health Research Institute

    collaborator OTHER
  • St. Joseph's Healthcare Hamilton

    collaborator OTHER
  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Jorge Wong, MD MPH FRCPC · PHRI, Hamilton Health Sciences, McMaster University

  • Aristithes Doumouras, MD MPH FRCSC · St. Joseph's Healthcare, McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-30
Primary Completion
2023-02-28
Completion
2023-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04226664 on ClinicalTrials.gov